Mr. Saundercook’s notable recent engagements include leading the transformation office of a nationwide corporate- and home-health services provider, including launching a COVID vaccine provider program to corporate clients and municipalities; and serving as interim CEO of a newly acquired med device manufacturing business unit, for which he tripled production capacity of their flagship product while growing EBITDA and enabling operational integration.

Mr. Saundercook also managed the transition services agreement after the divestiture of a medical solutions client’s anesthesia business and identified initiatives to eliminate over $40 million in stranded cost. He established a C-level Enterprise Program Management Office within a large, global medical device manufacturer that addressed on-plan progress and transparency during the divestiture of a business unit generating $1 billion annually, the rebranding and cost-out within the remaining device enterprise, and identification and elimination of barriers to growth.

Prior to joining A&M, Mr. Saundercook was with Acelity, an industry leader in negative pressure wound therapy and incision management, where he led an enterprise-wide program management office that focused on short- and long-term revenue and EBITDA improvement efforts and was directly accountable to the C-level leadership team.

At Acelity, Mr. Saundercook also led a program war room within a U.K.-based product development unit to accelerate product launches and ensure effective coordination with commercial and operations teams. He was responsible for a turnaround of a finance and order-to-cash shared services center in Budapest and for a global effort to reduce indirect spending by $55 million annually.

Mr. Saundercook holds a bachelor’s degree in communications from North Carolina State University. He is a certified Lean Six Sigma Black Belt.